Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT06754176
- Status
- Recruiting
Conditions
- Atrial Fibrillation (AF)
- Atrial Fibrillation (Paroxysmal)
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Alcohol Consumption Randomized Instructions — BEHAVIORALAlcohol Avoidance: In this intervention assignment, participants will be instructed to avoid drinking alcohol for this day. Alcohol Non-Avoidance: In this intervention assignment, participants will be allowed to drink alcohol for this day.
Study Details
The goal of this study is to assess the short-term effects of minimal and moderate drinking on atrial fibrillation (AFib) episodes in a real-world population diagnosed with 'come-and-go'/paroxysmal AFib. The question it aims to answer is: Is there a greater occurrence of AFib episodes when participants are allowed to consume alcohol according to random assignment? Participants will: * Be given daily random assignments to avoid or not to avoid alcohol * Wear an adhesive electrocardiographic (ECG) heart monitor * Wear a wrist-worn fitness tracker * Wear an anklet transdermal alcohol monitor * Wear an adhesive glucose monitor * Complete morning and evening surveys daily Participants may be compensated up to $50 for full completion of the study. This study can be done in-person or remote.
Key Dates
- Start date
- Apr 17, 2025
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2026
- Completion
- Aug 31, 2029
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- OTHER
Arms
- Experimental: Alcohol Non-Avoidance Case-Crossover ArmOn a given day of the 14-day study period, participants may be randomly assigned to not avoid consuming alcohol. All participants will be instructed that any alcohol consumed should not be more than 2 drinks in a 24 hour period for men and not more than 1 drink in a 24 hour period for women. The frequency of randomization will be tailored to the baseline usual frequency of alcohol consumption: For example, those who drink an average of 4 days a week/don't drink 3 days a week will have their randomization programmed to assure an average of 7 non-drinking days over the two-week period. Participants will not receive the same randomization assignment more than two consecutive days in a row. Participants will press a button on their continuously recording ECG monitor to time-stamp every alcohol drink consumed.
- Experimental: Alcohol Avoidance Case-Crossover ArmOn a given day of the 14-day study period, participants may be randomly assigned to avoid consuming alcohol. The frequency of randomization will be tailored to the baseline usual frequency of alcohol consumption: For example, those who drink an average of 4 days a week/don't drink 3 days a week will have their randomization programmed to assure an average of 7 non-drinking days over the two-week period. Participants will not receive the same randomization assignment more than two consecutive days in a row.
Primary Outcome Measure
Presence or Absence of Discrete Atrial Fibrillation Episodes [ Time Frame: 2 weeks ]
Central Contacts
- Gregory M Marcus, MD, MAS415-476-5706
- Hannah H Oo, BS415-476-4999
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCSF Medical Center at Mission Bay | San Francisco | California | 94158 | |
| UCSF Medical Center at Parnassus | San Francisco | California | 94143 |
Find similar trials in San Francisco, CA
Related Studies
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)PHASE3 · Recruiting · Anthos Therapeutics, Inc. · Birmingham, Alabama
- Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial FibrillationRecruiting · Arga Medtech SA · Birmingham, Alabama
- Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation SeverityRecruiting · University of California, San Francisco · San Francisco, California
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With AnticoagulationPHASE2 · Recruiting · Regeneron Pharmaceuticals · Dothan, Alabama